Testing a new early Parkinson's disease treatment

This trial is testing whether BHV-8000, an experimental medication, can help people with early Parkinson's disease manage their symptoms safely and effectively. Researchers will compare the medication at two different doses against a placebo (a dummy pill with no active ingredient) to see how well it works. After the first year, all participants will have the opportunity to receive the actual medication to see longer-term effects.

Parkinson's disease is a progressive condition that affects movement, and current treatment options may not work well for everyone or may cause side effects. This trial exists to see if this new medication could offer another treatment option for people in the early stages of the disease, when starting treatment might help slow progression.